(Pt) 的衍生品 (Pt) 的衍生品
Hana Kostrhunova1, Brondwyn S McGhie2, Lenka Markova1
1Institute of Biophysics, Czech Academy of Sciences, Kralovopolska 135, CZ-61200 Brno, Czech Republic.
新的 (IV) 预制药结合了 (II) 复合物与迪克洛菲纳克,显示出增强的抗癌活性和选择性. 这些新型化合物抑制癌细胞糖解和线粒体功能,诱导免疫细胞死亡.
科学领域:
- 药用化学 医学化学
- 癌症生物学 癌症生物学
- 药物开发 药物开发
背景情况:
- (((II) 复合物[Pt ((1S,2S-diaminocyclohexane) ((5,6-dimethyl-1,10-phenanthroline) ]2+ (PtII56MeSS, 1) 显示了广泛的抗癌效应,但具有局限性.
- 需要进一步阐明PtII56MeSS的确切作用机制和毒性概况.
研究的目的:
- 为了合成和评估新的 (IV) 前药物.
- 研究这些Pt(IV) 复合物的生物特性和作用机制,特别是它们与二二 (DCF) 的组合.
主要方法:
- 合成含有PtII56MeSS和二二 (DCF) 的制药.
- 对癌细胞系中的抗增殖活性,选择性和作用机制的评估.
- 对糖解,线粒体潜能和诱导细胞死亡,包括免疫细胞死亡的影响的评估.
主要成果:
- Pt(IV) 前药具有多式作用机制,结合了 PtII56MeSS 和 DCF 的作用.
- 狄克洛菲纳克配体通过抑制乳酸转运体,破坏糖解和线粒体潜能来增强抗增殖活性和选择性.
- Pt(IV) 综合体选择性地诱导癌细胞死亡,含有DCF的综合体触发免疫细胞死亡的标志.
结论:
- 新型Pt(IV) 前药与母Pt(II) 复合物相比,提供了更好的抗癌疗效和选择性.
- 加入DCF对于增强活性和诱导免疫细胞死亡至关重要,这表明新型癌症疗法的潜力.
更多相关视频
12:08Catalytic Reactions at Amine-Stabilized and Ligand-Free Platinum Nanoparticles Supported on Titania During Hydrogenation of Alkenes and Aldehydes
Published on: June 24, 2022
10:42Combining Solid-state and Solution-based Techniques: Synthesis and Reactivity of ChalcogenidoplumbatesII or IV
Published on: December 29, 2016
相关概念视频
Properties of Transition Metals
Valence Bond Theory
Coordination Compounds and Nomenclature
EDTA: Chemistry and Properties
Stereoisomerism
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
Crystal Field Theory - Tetrahedral and Square Planar Complexes
Crystal field theory (CFT) is applicable to molecules in geometries other than octahedral. In octahedral complexes, the lobes of the dx2−y2 and dz2 orbitals point directly at the ligands. For tetrahedral complexes, the d orbitals remain in place, but with only four ligands located between the axes. None of the orbitals points directly at the tetrahedral ligands. However, the dx2−y2 and dz2 orbitals (along the Cartesian axes) overlap with the ligands less than the dxy,...
